Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2022.361 | Safety and clinical and virologic outcomes in COVID-19 patients with chronic kidney disease treated with nirmatrelvir-ritonavir |
Dr. CHOW Kai Ming 周啟明 |
2023.123 | HLA-typing of donor-origin cells enriched from urine-derived cell culture of kidney transplanted recipients | Dr. CHOW Kai Ming |
2009.481 | Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis | Dr Chow Kai Ming |
2017.296 | Patient discharge information survey on inpatient service |
Dr. CHOW Kai Ming 周啟明 |
2017.147 | Effect of Erythropoiesis-Stimulating Agent therapy in Patients Receiving Palliative Care of Chronic Kidney Disease |
Dr. CHOW Kai Ming 周啟明 |
2015.197 | Randomized Controlled Trial of Straight versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients |
Dr. CHOW Kai Ming 周啟明 |
2016.067 | A practice model to enhance the provision of nursing care to manage sexual functioning in gynaecological cancer patients in Hong Kong |
Dr. CHOW Ka Ming 周嘉明 |
2017.087 | A risk prediction model to identify and motivate high-risk women for endometrial cancer screening in Hong Kong |
Dr. CHOW Ka Ming 周嘉明 |
2017.098 | Development of a practice model to promote medication safety and prevent drug administration errors |
Dr. CHOW Ka Ming 周嘉明 |
2017.692 | A culturally-adapted Women’s Wellness After Cancer programme for reducing psychological distress and improving health-related quality of life among Hong Kong gynaecological cancer survivors |
Dr. CHOW Ka Ming 周嘉明 |
2015.343 | The use of traditional Chinese medicine in preventing and managing oral ulcers: a feasibility study |
Prof. CHOW Ka Ming 周嘉明 |
2016.192 | Developing a multi-disciplinary psycho-educational intervention programme for infertile Hong Kong women planning for IVF to reduce psychological distress and improve marital relationships and pregnancy rates |
Prof. CHOW Ka Ming 周嘉明 |
2014.501 | A randomized controlled trial of psycho-educational interventions for reducing uncertainty and anxiety, and improving sexual functioning among gynecological cancer patients in Hong Kong | Dr. CHOW Ka Ming |
2023.357 | An Empirical Research of a Multimodal Decision Aid to Support Shared Decision-Making among Women Newly Diagnosed with Breast Cancer | Dr. CHOW Ka Ming |
2021.350 | Aetiology and treatment of breast pain in Hong Kong Chinese lactating mothers: A prospective cohort study |
Dr. CHOW Ka Ming 周嘉明 |
2022.416 | Randomised controlled trial of a multimodal couple-coping intervention to enhance couples’ sexual adjustment after treatment for premenopausal breast cancer | Dr. CHOW Ka Ming |
2021.276 | A multimodal cancer rehabilitation programme promoting sense of coherence for women treated for gynaecological cancer: A randomised controlled trial |
Dr. CHOW Ka Ming 周嘉明 |
2022.430 | A proactive child protection programme for mothers with psychological distress: A pilot project with outcome evaluation | Dr. CHOW Ka Ming |
2012.471 | A randomized controlled trial of psychoeducational interventions for improving sexual functioning, quality of life, and psychological outcomes among gynecological cancer patients in Hong Kong | Ms Chow Ka Ming |
2012.336 | Psychoeducational interventions for gynecological cancer patients in Hong Kong | Ms Chow Ka Ming |
2018.112 | Rebuilding sexuality and intimacy after treatment for gynaecological cancer, through a nurse-led sexual rehabilitation intervention: a randomised controlled trial |
Dr. CHOW Ka Ming 周嘉明 |
2019.135 | Counselling practicum for community clients with mental illness |
Ms. CHOW Jessie King Yan 周景欣 |
2018.562 | Efficacy of Mindfulness Born Peace and Happiness (MBPH) – a new Mindfulness-based Intervention based on the teachings of Thich Nhat Hanh: A randomized controlled trial on common mental disorders |
Ms. CHOW Jackie Cheuk Kwan 周卓君 |
2017.029 | The effect of a new ankle foot orthosis on gait symmetry for stroke patient |
Mr. CHOW Hung Yu 周鴻譽 |
2008.537 | Patients | Phsyiotherapist I Chow Hon Yuen |
2012.274 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events | Dr. CHOW Francis Chun-Chung |
2009.533 | BOOST: INTENSIFY ALL A Pan Asian trial comparing efficacy and safety of NN5401 and biphasic insulin aspart 30 in type 2 diabetes. A 26-week trial, randomised, open-label, two-arm, parallel-group, treat-to-target study comparing efficacy and safety of the soluble insulin analogue combination (SIAC) twice daily with biphasic insulin aspart 30 twice daily, with or without metformin in subjects with type 2 diabetes in inadequate glycaemic control on once or twice daily insulin regimen with or without metformin | Dr Chow Francis Chun-Chung |
2009.532 | BEGIN: ONCE ASIA A Pan Asian trial comparing efficacy and safety of insulin NN1250 and insulin glargine as add on to OAD(s) in subjects with type 2 diabetes. A 26-week randomised, confirmatory, controlled, open label, multicentre, multinational treat-to-target trial comparing the efficacy and safety of SIBA and insulin glargine, both injected once daily as add on to current OAD treatment in insulin na・e subjects with type 2 diabetes mellitus qualifying for more intensified treatment | Dr Chow Francis Chun-Chung |
2009.144 | SCALE -Obesity and Pre-diabetes Satiety and Clinical Adiposity- Liraglutide Evidence in Nondiabetic and Diabetic Subjects Effect of liraglutide on body weight in non-diabetic obese subjects or overweight subjects with comorbidities A randomised, double-blind, placebo controlled, parallel group, multi-centre, multinational trial with stratification of subject to either 56 or 160 weeks of treatment based on pre-diabetes status at randomisation | Dr. CHOW Francis Chun Chung |
2010.511 | A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk. The CAROLINA Trial. | Dr. CHOW Francis Chun Chung |
2013.409 | Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin and/or TZD in subjects with type 2 diabetes | Dr. CHOW Francis Chun Chung |
2015.370 | A 24-week, multinational, multicentre, randomised, open label, parallel-group treat to target trial to compare efficacy and safety of thrice daily versus twice daily NovoMix®30 (Biphasic insulin aspart 30) in subjects with type 2 diabetes inadequately controlled with basal insulin |
Dr. CHOW Francis Chun Chung 周振中 |
2017.233 | Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes |
Dr. CHOW Francis Chun Chung 周振中 |
2015.470 | Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes |
Dr. CHOW Francis Chun Chung 周振中 |
2007.494 | A Randomised, Double-blind, Active-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5.0 mg, administered orally once daily) Compared to Glimepiride (1 to 4 mg once daily) Over Two Years, In Type 2 Diabetic Patients with Insufficient Glycaemic Control Despite Metformin Therapy | Dr. Chow Francis C. C. |
2018.526 | A randomized, 24 week, active-controlled, open-label, 3-arm, parallel-group multicenter study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabetic drug(s) |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2019.222 | The effect of real-time continuous glucose monitoring (rtCGM) on improving time-in-range in suboptimally controlled type 2 diabetes patients on multiple daily injections (MDI) |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2022.464 | A study of the safety and tolerability of gold nanoparticles in a topical hydrogel in healthy volunteers | Dr. CHOW Elaine Yee Kwan |
2021.709 | A Multi-center, Randomized, Double-Blinded, Parallel, Vildagliptin and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Treatment-naive Patients with Type 2 Diabetes Mellitus |
Prof. CHOW Elaine Yee Kwan 周怡君 |
2022.293 | A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy | Prof. CHOW Elaine Yee Kwan |
2021.716 | The Impact of High or Low FODMAP diets on Postprandial glucose response and Gut Microbiota in Individuals with Prediabetes treated with Metformin: A Randomized Crossover Controlled-Feeding Trial |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2019.605 | Continuous glucose monitoring as an adjunct to lifestyle modification in individuals with impaired glucose tolerance: a randomised controlled trial |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2019.352 | A Phase Ib/IIa, Single Ascending Dose Study of the Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients with Type 2 Diabetes Mellitus | Dr. CHOW Elaine Yee Kwan |
2018.106 | Targeted screening for familial hypercholesterolaemia in Hong Kong Chinese patients with established coronary artery disease |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2018.621 | Randomised controlled trial of flash glucose monitoring in reduction of hypoglycaemia in diabetes patients with chronic kidney disease |
Dr. CHOW Elaine Yee Kwan 周怡君 |
2020.312 | Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic sessions) in Patients with Diabetes | Prof. CHOW Elaine Yee Kwan |
2015.563 | Beta cell function and insulin sensitivity in Chinese with young onset type 2 diabetes and their siblings – a pilot study | Dr. CHOW Elaine Yee Kwan |
2016.572 | Effectiveness and safety study of the percutaneous optical fibre glucose sensor (FiberSense) for home use in diabetic and prediabetic individuals | Dr. CHOW Elaine Yee Kwan |
2017.359 | A pilot study to describe the glycemic variability of insulin glargine 300U/ml versus NPH (Neutral Protamine Hagedorn) in the insulin-naive type 2 diabetes patients following a patient-adjusted insulin algorithm in Hong Kong | Dr. CHOW Elaine Yee Kwan |
2011.235 | Genetic analysis of familial hypercholesterolaemia in Hong Kong Chinese population | Dr. CHOW Elaine Yee Kwan |
Page 169 of 254.